Double edged sword.2 Apr 2020 09:25
I am long the stock and have been for some time.
Whilst the covid crisis poses opportunities, it must also seriously effect on going clinical trials and potential clinical trials for unrelated drugs.
I’m guessing this is why we haven’t as yet had another contract win announced ?